Pediatric Grand Rounds (RECORDING) Academic Activism: Choosing the Right Place and the Right Time

This presentation is a recording of a Stanford Pediatric Grand Rounds Session.  World-renowned experts will present the latest research, practice guidelines, and treatment protocols to advance best practices in the care of pediatric patients. These online recordings will provide pediatricians and family physicians with up-to-date clinical information on a wide range of clinical issues encountered in daily pediatric practice. In this session, we will learn effective strategies of how to overcome clear evidence of bigotry, systematic racism, or both to advance the medical care of children and adults with sickle cell disease.

  Release Date: December 16, 2022
  Expiration Date: December 15, 2023
  Estimated Time to Complete: 1.0 hour
  Registration Fee: FREE
 *Originally recorded 09/16/2022.

1. Learn about the clinical history of improved survival of children and adults with sickle cell disease in the current era.
2. Review current successes and failures in the curative treatment of sickle cell disease in children and adults.
3. Discuss clinical and genetic strategies to improve health outcomes before and after curative therapy in children and adults with sickle cell disease.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 1.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require accommodations, please contact the CME Conference Coordinator.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography

Asare, E. V., Olayemi, E., Boafor, T., Dei-Adomakoh, Y., Mensah, E., Ghansah, H.,
Osei-Bonsu, Y., Crabbe, S., Musah, L., Hayfron-Benjamin, C., Covert, B., Kassim, A. A.,
James, A., Rodeghier, M., DeBaun, M. R., & Oppong, S. A. (2017). Implementation of
multidisciplinary care reduces maternal mortality in women with sickle cell disease living
in low-resource setting. American journal of hematology, 92(9), 872–878.
https://doi.org/10.1002/ajh.24790

Bolaños-Meade, J., Fuchs, E. J., Luznik, L., Lanzkron, S. M., Gamper, C. J., Jones, R. J., &
Brodsky, R. A. (2012). HLA-haploidentical bone marrow transplantation with
posttransplant cyclophosphamide expands the donor pool for patients with sickle cell
disease. Blood, 120(22), 4285–4291. https://doi.org/10.1182/blood-2012-07-438408

DeBaun, M. R., Ghafuri, D. L., Rodeghier, M., Maitra, P., Chaturvedi, S., Kassim, A., & Ataga,
K. I. (2019). Decreased median survival of adults with sickle cell disease after adjusting
for left truncation bias: a pooled analysis. Blood, 133(6), 615–617.
https://doi.org/10.1182/blood-2018-10-880575

DeBaun, M. R., Gordon, M., McKinstry, R. C., Noetzel, M. J., White, D. A., Sarnaik, S. A.,
Meier, E. R., Howard, T. H., Majumdar, S., Inusa, B. P., Telfer, P. T., Kirby-Allen, M.,
McCavit, T. L., Kamdem, A., Airewele, G., Woods, G. M., Berman, B., Panepinto, J. A.,
Fuh, B. R., Kwiatkowski, J. L., Casella, J. F. (2014). Controlled trial of transfusions
for silent cerebral infarcts in sickle cell anemia. The New England journal of medicine,
371(8), 699–710. https://doi.org/10.1056/NEJMoa1401731

de la Fuente, J., Dhedin, N., Koyama, T., Bernaudin, F., Kuentz, M., Karnik, L., Socié, G.,
Culos, K. A., Brodsky, R. A., DeBaun, M. R., & Kassim, A. A. (2019). Haploidentical
Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide Plus
Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an
International Learning Collaborative. Biology of blood and marrow transplantation :
journal of the American Society for Blood and Marrow Transplantation, 25(6),
1197–1209. https://doi.org/10.1016/j.bbmt.2018.11.027

Herron, S., Bacak, S. J., King, A., & DeBaun, M. R. (2003). Inadequate recognition of
education resources required for high-risk students with sickle cell disease. Archives of
pediatrics & adolescent medicine, 157(1), 104.
https://doi.org/10.1001/archpedi.157.1.104

King, A., Herron, S., McKinstry, R., Bacak, S., Armstrong, M., White, D., & DeBaun, M.
(2006). A multidisciplinary health care team's efforts to improve educational attainment
in children with sickle-cell anemia and cerebral infarcts. The Journal of school health,
76(1), 33–37. https://doi.org/10.1111/j.1746-1561.2006.00064.x

McNeil, D. G. Jr. (2017). Easing the Toll of Sickle Cell Disease in Childbirth. The New
York Times: Global Health.
https://www.nytimes.com/2017/01/02/health/easing-the-toll-of-sickle-cell-disease-in-chil
dbirth.html

Mentzer, W. C., Heller, S., Pearle, P. R., Hackney, E., & Vichinsky, E. (1994). Availability of
related donors for bone marrow transplantation in sickle cell anemia. The American
journal of pediatric hematology/oncology, 16(1), 27–29.

Swarray-Deen, A., Asare, E. V., Brew, R. A., Ayete-Nyampong, J. B., Dei-Adomakoh, Y.,
Olayemi, E., Mensah, E., Osei-Bonsu, Y., Crabbe, S., Ghunney, W. K.,
Hayfron-Benjamin, C., Beyuo, T., Boafor, T., Kassim, A. A., Rodeghier, M., DeBaun, M.
R., & Oppong, S. A. (2022). Sustainability of low maternal mortality in pregnant women
with SCD in a low-resource setting. Blood advances, 6(7), 1977–1980.
https://doi.org/10.1182/bloodadvances.2021005942

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education. 

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Ke-You Zhang, MD
Stanford University

Co-Course Director

Alan R. Schroeder, MD
Clinical Professor
Stanford University

Co-Course Director and Reviewer

Nothing to disclose

Olivera Marsenic Couloures, MD
LPCH

Course Director and Reviewer

Nothing to disclose

Michael DeBaun, MD, MPH

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Global Blood Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis AG|Paid consultant-Forma Pharmaceutical|Independent Contractor (included contracted research)-Vertex/CRISPR Therapeutics (Relationship has ended)

Debra Babcock, MD
Stanford Childrens (PCHA)

Planner

Nothing to disclose

Lisa Jo Chamberlain, MD
Professor of Pediatrics – General Pediatrics
Stanford Children's Health

Planner

Nothing to disclose

Baraka Dechelle Floyd, MD
Clinical Assistant Professor and Associate Chair for Diversity, Equity, and Inclusion
Stanford University School of Medicine

Planner

Nothing to disclose

Charles Gawad, MD, PhD
Associate Professor
Stanford

Planner

Ownership-BioSkryb Genomics

Allison Guerin, EdD
Stanford

Planner

Nothing to disclose

Mary Beth Leonard, MD, MSCE
Arline and Pete Harman Professor and Chair, Department of Pediatrics
Stanford University

Planner

Nothing to disclose

Ryan Lion, MD, MS
Stanford University

Planner

Nothing to disclose

Lauren E O'Brien, MD
Clinical Assistant Professor
LPCH

Planner

Nothing to disclose

Stephen J Roth, MPH, MD
Attending, Cardiovascular ICU
Lucile Packard Children's Hospital Stanford

Planner

Nothing to disclose

Stephanie Squires, MD
Pediatric Hospital Medicine Fellow
Stanford Health Care/ Stanford Children's Hospital

Planner

Nothing to disclose